Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 12, 2019
Adenosine and the Cardiovascular SystemAllison B Reiss, David Grossfeld, Lora J Kasselman, et al.
Medicina (Kaunas, Lithuania)|August 24, 2019
Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS SubstudyAllison B Reiss, Hirra A Arain, Lora J Kasselman, et al.
Rheumatic Diseases Clinics of North America|July 20, 2016
New Treatment Guidelines for Sjögren's DiseaseFrederick B Vivino, Steven E Carsons, Gary Foulks, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol effluxIryna Voloshyna, Isaac Teboul, Michael J Littlefield, et al.
Arthritis and Rheumatism|November 28, 2008
Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophagesAllison B Reiss, Steven E Carsons, Kamran Anwar, et al.
Journal of Traditional and Complementary Medicine|September 9, 2022
Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse modelLora J Kasselman, Heather A Renna, Iryna Voloshyna, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 16, 2009
Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosisAllison B Reiss, David W Wan, Kamran Anwar, et al.
Experimental and Molecular Pathology|January 12, 2021
Effect of oxytocin on lipid accumulation under inflammatory conditions in human macrophagesAriel Karten, Nicholas A Vernice, Heather A Renna, et al.
Plos One|September 15, 2011
Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patientMaggie Eidson, Justin Wahlstrom, Aimee M Beaulieu, et al.
Arthritis Care & Research|July 9, 2016
Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal PainSteven E Carsons, Frederick B Vivino, Ann Parke, et al.
Pageof 4